Evidence map›Paper›PMID 39508974›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.

Raquel Sánchez-Vañó, Julia Balaguer, Isabel Borrego-Dorado, Alba Esteban-Figueruelo, Cristina Gámez, Raquel Hladun, Ricardo López-Almaraz, Mercedes L Llempén, Sonia Rodado, Pedro M Rubio-Aparicio

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raquel Sánchez-VañóServicio de Medicina Nuclear, Hospital Universitario La Fe, Valencia, Spain.
Julia BalaguerServicio de Hemato-Oncología Pediátrica, Hospital Universitario La Fe and Polytechnic Hospital, Valencia, Spain. balaguer_jul@gva.es.ORCID http://orcid.org/0000-0002-7346-6499
Isabel Borrego-DoradoServicio de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Seville, Spain.
Alba Esteban-FiguerueloServicio de Medicina Nuclear, Hospital Universitario Cruces, Barakaldo, Spain.
Cristina GámezServicio de Medicina Nuclear, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Raquel HladunServicio de Hemato-Oncología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Ricardo López-AlmarazUnidad de Hemato-Oncología Pediátrica, Hospital Universitario Cruces and Pediatric Oncology Group Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Mercedes L LlempénServicio de Oncología Pediátrica, Hospital Universitario Virgen del Rocío, Seville, Spain.
Sonia RodadoServicio de Medicina Nuclear, Hospital Universitario La Paz, Madrid, Spain.
Pedro M Rubio-AparicioServicio de Hemato-Oncología Pediátrica, Hospital Universitario La Paz, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma (NB) is the most common extracranial solid cancer in children. Despite intensive multimodality treatment, long-term survival of patients with high-risk NB, which comprises more than half of all cases, remains poor. Nuclear medicine is key in diagnosis, staging, response assessment and long-term follow-up of NB. The emergence of novel tracers and the increasing complexity of studies require updated guidelines for nuclear medicine imaging in NB. Standardising diagnostic techniques are essential for improving study comparability and ensuring test quality. This article aims to provide a comprehensive review of NB radionuclide diagnostic imaging, including its characteristics, accuracy, advantages, and limitations. It offers practical recommendations to multidisciplinary teams responsible for treating patients with NB. This review summarises the opinions of leading experts from the Neuroblastoma Spanish Group within the Spanish Society of Paediatric Haematology and Oncology (SEHOP) and the Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM).

Indexed as

NeuroblastomaNuclear MedicinePractice Guidelines as TopicRadionuclide ImagingChildHumansRadiopharmaceuticalsRadiopharmaceuticals3-IodobenzylguanidineConsensusDiagnosisNeuroblastomaPositron-Emission TomographyRadionuclide imaging

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.